antivirotics, gene trap, H1N1, influenza, macrophage, Pandemic, Swine Flu, Vaccine, viral infection, Zirus, XVIVO
Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.
“Few are as dedicated and diligent as the XVIVO team.”
Vice President, Management Supervisor, Ogilvy Healthworld